Authors:
CALDERWOOD S
DOYLE JJ
ROLLANDGRINTON M
ZAFAR M
ROIFMAN C
FREEDMAN MH
SAUNDERS EF
Citation: S. Calderwood et al., WHEN ARE 2ND ALLOGENEIC BONE-MARROW TRANSPLANTS INDICATED IN PEDIATRIC-PATIENTS, International journal of pediatric hematology/oncology, 5(5), 1998, pp. 337-343
Authors:
CHATTERGOON DS
SAUNDERS EF
KLEIN J
CALDERWOOD S
DOYLE J
FREEDMAN MH
KOREN G
Citation: Ds. Chattergoon et al., AN IMPROVED LIMITED SAMPLING METHOD FOR INDIVIDUALIZED BUSULFAN DOSING IN BONE-MARROW TRANSPLANTATION IN CHILDREN, Bone marrow transplantation, 20(5), 1997, pp. 347-354
Authors:
ROWLINGS PA
PRZEPIORKA D
KLEIN JP
GALE RP
PASSWEG JR
HENSLEEDOWNEY PJ
CAHN JY
CALDERWOOD S
GRATWOHL A
SOCIE G
ABECASIS MM
SOBOCINSKI KA
ZHANG MJ
HOROWITZ MM
Citation: Pa. Rowlings et al., IBMTR SEVERITY INDEX FOR GRADING ACUTE GRAFT-VERSUS-HOST DISEASE - RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE, British Journal of Haematology, 97(4), 1997, pp. 855-864
Authors:
CALDERWOOD S
ROLLANDGRINTON M
DOYLE JJ
FREEDMAN MH
SAUNDERS EF
Citation: S. Calderwood et al., HIGH-DOSE ETOPOSIDE AND TBI CONDITIONING FOLLOWED BY ALLOGENEIC BMT FOR HIGH-RISK PEDIATRIC ALL, Blood, 90(10), 1997, pp. 4350-4350
Authors:
YEAGER AM
AMYLON M
WAGNER J
CALDERWOOD S
ANASETTI C
SENDER L
JACOBS C
BENYUNES M
Citation: Am. Yeager et al., ALLOGENEIC STEM-CELL TRANSPLANTATION FROM HLA-HAPLOIDENTICAL RELATIVES AS TREATMENT FOR CHILDREN WITH HEMATOLOGIC MALIGNANCY - A PHASE I IISTUDY USING MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PBPCS) THAT HAVE UNDERGONE CD34 SELECTION FOLLOWED BY CD2 DEPLETION/, Blood, 90(10), 1997, pp. 958-958
Authors:
FOULADI M
HERMAN R
ROLLANDGRINTON M
BLANCHETTE V
CALDERWOOD S
DOYLE JJ
LEAKER M
SAUNDERS EF
ZIPURSKY A
FREEDMAN MH
Citation: M. Fouladi et al., ACQUIRED APLASTIC-ANEMIA IN CHILDREN - COMPARISON OF OUTCOME OF BONE-MARROW TRANSPLANTATION (BMT) VERSUS IMMUNOSUPPRESSIVE THERAPY (IT) FROM 1977-1997, Blood, 90(10), 1997, pp. 1013-1013
Authors:
CALDERWOOD S
DOYLE JJ
HITZLER JK
SAUNDERS EF
FREEDMAN MH
Citation: S. Calderwood et al., ADMINISTRATION OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN CHILDREN WITH ACUTE MYELOGENOUS LEUKEMIA - A NOTE OF CAUTION, Bone marrow transplantation, 18(1), 1996, pp. 87-91
Authors:
SAXON BR
DOYLE J
FREEDMAN M
SAUNDERS EF
CALDERWOOD S
Citation: Br. Saxon et al., COMPARISON BETWEEN MELPHALAN AND BUSULFAN CYCLOPHOSPHAMIDE CONDITIONING FOR AUTOLOGOUS BMT IN PEDIATRIC AML/, Blood, 88(10), 1996, pp. 495-495
Authors:
CALDERWOOD S
ROLLANDGRINTON M
DOYLE JJ
FREEDMAN MH
SAUNDERS EF
Citation: S. Calderwood et al., OUTCOME FOLLOWING 2ND ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) INPEDIATRIC-PATIENTS, Blood, 88(10), 1996, pp. 2448-2448
Authors:
DI YP
REPASKY E
LASZLO A
CALDERWOOD S
SUBJECK J
Citation: Yp. Di et al., HSP70 TRANSLOCATES INTO A CYTOPLASMIC AGGREGATE DURING LYMPHOCYTE-ACTIVATION, Journal of cellular physiology, 165(2), 1995, pp. 228-238
Authors:
CHATTERGOON DS
CALDERWOOD S
DOYLE J
FREEDMAN MH
KOREN G
SAUNDERS EF
Citation: Ds. Chattergoon et al., TOXICITY AND ENGRAFTMENT AFTER INDIVIDUALIZED BUSULFAN (BU) DOSING INBONE-MARROW TRANSPLANTATION (BMT) IN CHILDREN - INTERIM RESULTS, Blood, 86(10), 1995, pp. 862-862
Authors:
CALDERWOOD S
SAUNDERS EF
DOYLE JJ
FREEDMAN MH
POON A
ROCK G
Citation: S. Calderwood et al., PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTION AND TRANSPLANTATION IN THE MANAGEMENT OF CHILDHOOD-CANCER, Blood, 86(10), 1995, pp. 3747-3747
Authors:
CALDERWOOD S
ROMEYER F
BLANCHETTE V
CHAN H
DOYLE J
GREENBERG M
LORENZANA A
MALKIN D
SAUNDERS F
WEITZMAN S
ZIPURSKY A
FREEDMAN MH
Citation: S. Calderwood et al., CONCURRENT RHGM-CSF DOES NOT OFFSET MYELOSUPPRESSION FROM INTENSIVE CHEMOTHERAPY - RANDOMIZED PLACEBO-CONTROLLED STUDY IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA, American journal of hematology, 47(1), 1994, pp. 27-32
Authors:
CALDERWOOD S
BLANCHETTE V
DOYLE J
FREEDMAN J
STRONCEK D
ZIPURSKY A
Citation: S. Calderwood et al., IDIOPATHIC THROMBOCYTOPENIA AND NEUTROPENIA IN CHILDHOOD, The American journal of pediatric hematology/oncology, 16(2), 1994, pp. 95-101
Authors:
HITZLER JK
DOYLE J
SAUNDERS EF
ROLLANDGRINTON M
FREEDMAN MH
CALDERWOOD S
Citation: Jk. Hitzler et al., SURVIVAL AND LENGTH OF HOSPITALIZATION AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR AML IN CHILDREN RECEIVING GM-CSF - A NOTE OF CAUTION, Blood, 84(10), 1994, pp. 10000091-10000091
Authors:
VEYS P
SAUNDERS F
CALDERWOOD S
DOYLE J
MORGAN G
KAMELREID S
PASSMORE J
CHESSELLS J
FREEDMAN M
Citation: P. Veys et al., THE ROLE OF GRAFT-VERSUS-LEUKEMIA IN BONE-MARROW TRANSPLANTATION FOR JUVENILE CHRONIC MYELOID-LEUKEMIA, Blood, 84(10), 1994, pp. 10000337-10000337
Authors:
CHAN A
ROLLANDGRINTON M
DOYLE J
FREEDMAN MH
SAUNDERS EF
CALDERWOOD S
Citation: A. Chan et al., EFFECT OF RHGM-CSF ON OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PEDIATRIC-PATIENTS - A RETROSPECTIVE ANALYSIS, Blood, 84(10), 1994, pp. 10000705-10000705
Authors:
ZAKRIS E
SCHNITT S
SHIH L
CONNOLLY J
COHEN P
CALDERWOOD S
HARRIS J
Citation: E. Zakris et al., C-ERBB-2 ONCOGENE EXPRESSION IN RELATION TO THE EXTENT OF THE INTRADUCTAL COMPONENT IN INVASIVE DUCTAL CARCINOMAS, International journal of radiation oncology, biology, physics, 27, 1993, pp. 268-268